BetterLife Pharma Inc. BETRF
0.16 USD -0.02 (-10.06%)
At closeNov 3, 2026, 4:00 PM EST
0.1607 Day range 0.1713
0.028 52-week range 0.331
- YTD
- +403.13%
- 1 year
- +257.78%
News
newsfilecorp.com BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm Engagement to support expanded investor outreach as BetterLife advances BETR-001 toward planned clinical development in 2027 Vancouver, British Columbia--(Newsfile Corp. - October 27, 2026) -…
newsfilecorp.com BetterLife Pharma Appoints Professor Richard B. Lipton as Co-Chair of its Scientific Advisory Board Director of the Montefiore Headache Center and past President of the American Headache Society joins Professor Peter Goadsby in leading the SAB for BETR-001 Vancouver, British Columbia--(Newsfile…
newsfilecorp.com BetterLife Pharma Appoints Sheila Leitzinger as Head of Clinical Operations Clinical development veteran to lead execution of the first-in-human study of BETR-001 ahead of programs in chronic cluster headache and chronic migraine Vancouver, British Columbia--(Newsfile Corp.…
defenseworld.net BetterLife Pharma Inc. (OTCMKTS:BETRF) Stock Short Interest Report for September BetterLife Pharma Inc. (OTCMKTS:BETRF - Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totaling…
newsfilecorp.com BetterLife Pharma Establishes Scientific Advisory Board for Headache Program; Professor Peter Goadsby Appointed Co-Chair Brain Prize co-recipient whose research identified CGRP as a central driver of migraine joins to guide development of BETR-001 in chronic cluster headache and chronic migraine Vancouver, British…
newsfilecorp.com BetterLife Pharma Addresses Notice of Civil Claim Filed by Steven Sangha Vancouver, British Columbia--(Newsfile Corp. - October 9, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), today issued a statement regarding a…
newsfilecorp.com BetterLife Pharma Announces Rescheduling and Reclassification of Annual General Meeting to Annual General and Special Meeting Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biotechnology company…
defenseworld.net BetterLife Pharma Inc. (OTCMKTS:BETRF) Sees Large Decrease in Short Interest BetterLife Pharma Inc. (OTCMKTS:BETRF - Get Free Report) was the target of a significant decrease in short interest in the month of September. As of September 15th, there was short interest totaling…
newsfilecorp.com BetterLife Pharma Appoints Charles Duncan as Director and Chair of the Audit Committee Vancouver, British Columbia--(Newsfile Corp. - August 31, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biotechnology company…
newsfilecorp.com BetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical Officer Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), a biotechnology company developing…
newsfilecorp.com BetterLife Pharma Prioritizes BETR-001 to Lead in Migraine and Headache Disorders, Targeting a Clinically Validated, FDA-Precedented Serotonergic Mechanism Fully non-hallucinogenic, oral, non-scheduled 5-HT2A neuroplastogen differentiates BETR-001 from every other 5-HT2A agonist program; depression and other psychiatric disorders retained as optional…
newsfilecorp.com BetterLife Engages Nucro-Technics to Complete the last GLP Toxicology Study of BETR-001 Required by the FDA for IND and Phase 1 Vancouver, British Columbia--(Newsfile Corp. - July 6, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") announces it has entered into an agreement…
newsfilecorp.com BetterLife Engages Syner-G to Oversee GMP Manufacturing of BETR-001 for IND and Phase 1 Vancouver, British Columbia--(Newsfile Corp. - June 25, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") announces it has entered into an…
feeds.newsfilecorp.com BetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND Filing Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") today announced
feeds.newsfilecorp.com BetterLife Pharma Announces Appointment of Doug Drysdale as Executive Chairman and Director Vancouver, British Columbia--(Newsfile Corp. - May 13, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the
newsfilecorp.com BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco Vancouver, British Columbia--(Newsfile Corp. - January 6, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), an emerging biopharmaceutical company…
thenewswire.com BetterLife Pharma Highlights Advantages of BETR-001 -- a Potent Neuroplastogen VANCOUVER, British Columbia – TheNewswire - December 4, 2025 - BetterLife Pharma Inc. (“BetterLife” or the “Compa ny”) ( CSE: BETR / OTCQB: BETRF / FRA: NPAU ) , an emerging biotech company, focused…
thenewswire.com BetterLife Pharma Welcomes Daniel Carcillo as Corporate Advisor VANCOUVER, British Columbia, November 25, 2025 – TheNewswire - BetterLife Pharma Inc. (“BetterLife” or the “Compa ny”) ( CSE: BETR / OTCQB: BETRF / FRA: NPAU ) , an emerging biotech company, focused…
defenseworld.net Head-To-Head Analysis: Vivos Therapeutics (NASDAQ:VVOS) vs. BetterLife Pharma (OTCMKTS:BETRF) BetterLife Pharma (OTCMKTS:BETRF - Get Free Report) and Vivos Therapeutics (NASDAQ: VVOS - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will…
thenewswire.com USPTO Files ISSUE NOTIFICATION for BetterLife's BETR-001 Composition of Matter Patent VANCOUVER, British Columbia, June 18, 2025 – TheNewswire - BetterLife Pharma Inc. (“BetterLife” or the “Compa ny”) ( CSE: BETR / OTCQB : BETRF / FRA: NPAU ) , an emerging biotech company focused on…